Advances in the prevention and treatment of esophageal stricture after endoscopic submucosal dissection of early esophageal cancer

Y Zhang, B Zhang, Y Wang, J Zhang, Y Wu… - Journal of …, 2020 - degruyter.com
Endoscopic submucosal dissection (ESD) has become the main treatment for early
esophageal cancer. While treating the disease, ESD may also cause postoperative …

[HTML][HTML] Ability of human umbilical cord mesenchymal stem cells to repair chemotherapy-induced premature ovarian failure

J Shen, D Cao, JL Sun - World journal of stem cells, 2020 - ncbi.nlm.nih.gov
BACKGROUND Premature ovarian insufficiency (POI) and premature ovarian failure (POF)
have become one of the major problems threatening women of childbearing age. Studies …

Long-term outcomes of endoscopic submucosal dissection for special type of esophageal cancer

Y Suzuki, K Nomura, A Matsui, D Kikuchi, K Ohashi… - Digestive …, 2023 - karger.com
Background: Esophageal cancers other than two types, squamous cell carcinoma (SCC)
and adenocarcinoma, are commonly referred to as special type of esophageal cancer …

[HTML][HTML] Lysyl oxidase and hypoxia-inducible factor 1α: biomarkers of gastric cancer

YL Han, L Chen, R Qin, GQ Wang, XH Lin… - World Journal of …, 2019 - ncbi.nlm.nih.gov
BACKGROUND Gastric cancer (GC) is one of the main causes of cancer mortality
worldwide. Recent studies on tumor microenvironments have shown that tumor metabolism …

[HTML][HTML] Esophageal cancer

Y Wang, SKR Mukkamalla, R Singh… - StatPearls …, 2024 - ncbi.nlm.nih.gov
Objectives: Identify the risk factors for esophageal cancer. Evaluate patients with clinical
features of esophageal cancer. Compare the various treatment approaches for esophageal …

PSME3 promotes lung adenocarcinoma development by regulating the TGF-β/SMAD signaling pathway

S Wang, Y Li, K Jin, K Suda, R Li… - Translational Lung …, 2024 - pmc.ncbi.nlm.nih.gov
Background Lung adenocarcinoma (LUAD) is one of the most common types of cancer
worldwide. Proteasome activator subunit 3 (PSME3) is a subunit of a proteasome activator …

Epidemiology and survival outcomes in adenosquamous carcinoma: a population-based study

C Cheng, Z Luo, W Xiong, Z Shi, H Tan - International Journal of Colorectal …, 2022 - Springer
Background The relationship between the location of the primary tumor and survival of
adenosquamous carcinoma (ASC) remains poorly understood. This study aimed to evaluate …

Clinical characteristics, prognosis, and nomogram for esophageal cancer based on adenosquamous carcinoma: a SEER database analysis

H Qian, X Ji, C Liu, Y Dang, X Li, G Zhang - Frontiers in Oncology, 2021 - frontiersin.org
Objective: Esophageal adenosquamous carcinoma (ASC) is a rare pathological type of
cancer. Its clinical features and prognosis is poorly understood. The purpose of this study …

Multi‐omics analyses reveal spatial heterogeneity in primary and metastatic oesophageal squamous cell carcinoma

H Huang, N Li, Y Liang, R Li, X Tong… - Clinical and …, 2023 - Wiley Online Library
Background Biopsies obtained from primary oesophageal squamous cell carcinoma (ESCC)
guide diagnosis and treatment. However, spatial intra‐tumoral heterogeneity (ITH) …

[HTML][HTML] Occurrence and Prognosis of Mixed Subtype Adenocarcinoma and Adeno-Squamous Carcinoma in Esophageal Cancer

D Zhang, T Lu, P Guo, F Zhao, Z Li, S Li - Journal of Cancer, 2024 - ncbi.nlm.nih.gov
Purpose: To gain a deeper understanding of the incidence and survival rates of rare
esophageal mixed adenoacanthoma (EAM) and esophageal mixed adeno-squamous …